Hilary Hammell
banner
hilary-marie.bsky.social
Hilary Hammell
@hilary-marie.bsky.social
De Novo Stage 4 NEC of the lung. RET+ w/ secondary BRAF v600e mutation. Family medicine physician. Wife and mother of two. Brain Mets. Finding Joy in sorrow. Turning pain into purpose.
Reposted by Hilary Hammell
As an oncologist, I get constant reminders that holidays are joyful & meaningful milestones, but not every yr & not for everyone. If you are with #grief, I hope this will remind you that you belong to something vast & are not alone.

#MedSky #OncSky #LongCovid

www.nytimes.com/2024/12/20/s...
Grief Makes Us Time Travelers (Gift Article)
A neuroscientist studying memory, I used to believe time was linear. Then my mother had a stroke.
www.nytimes.com
December 20, 2024 at 5:08 PM
Reposted by Hilary Hammell
6. Will end on a positive note -- trust in scientists, especially relative to other groups, remains high, with over three quarters of the population saying they have confidence scientists act in the best interest of the public. Keep doing the important work that you're doing 🤍
November 14, 2024 at 9:50 PM
Reposted by Hilary Hammell
@iaslc.bsky.social & LCRF announced the recipient of their first-ever IASLC - LCRF Team Science Research Grant on the Next Step in the Cure of Oncogene-Driven Lung Cancers. The $2.5M, 4-year grant was awarded to a team led by David A. Barbie, MD, of @danafarber.bsky.social. LCRF.org/teamscience2024
November 19, 2024 at 3:05 PM
Reposted by Hilary Hammell
Allison Davidson was diagnosed with Stage 4 #RET+ lung cancer at age 50. She had metastasis to her brain, spine, and liver. Thanks to research, she is able to enjoy her children as they grow up. #BecauseOfResearch #lcsm #lcam

@younglungcancer.bsky.social @oncogenecancer.bsky.social
November 21, 2024 at 4:29 PM
Reposted by Hilary Hammell
Great analysis of DLL3 expression in SCLC and difficult to treat neuroendocrine neoplasms. Excited to see more biomarker driven approaches to advance care in such needed spaces.

www.nature.com/articles/s41...
Delta-like ligand 3 (DLL3) landscape in pulmonary and extra-pulmonary neuroendocrine neoplasms - npj Precision Oncology
npj Precision Oncology - Delta-like ligand 3 (DLL3) landscape in pulmonary and extra-pulmonary neuroendocrine neoplasms
www.nature.com
November 20, 2024 at 1:00 AM
Reposted by Hilary Hammell
Is sharing our writing a thing here? 😊
Proud of this piece because it represents the work of so many trying to make medicine and communication better for our patients. #MedSky
www.mayoclinicproceedings.org/action/showP...
November 19, 2024 at 3:42 PM
Reposted by Hilary Hammell
THEY ARE RIGHT. REFER TO THEM AS REPUBLICANS PARTY NO PICTURES NO NAME
November 18, 2024 at 1:22 AM